CERETEC (technetium tc-99m exametazime kit)
CERETEC is indicated for the treatment of Stroke; Intra-Abdominal Infection; Inflammatory Bowel Disease.
Details
- Status
- Prescription
- First Approved
- 1988-12-30
- Routes
- INJECTION
- Dosage Forms
- INJECTABLE
CERETEC Approval History
What CERETEC Treats
3 indicationsCERETEC is approved for 3 conditions since its original approval in 1988. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Stroke
- Intra-Abdominal Infection
- Inflammatory Bowel Disease
CERETEC Competitive Set
ProThree rings of competition based on shared molecular targets and treated indications.
Indication competitors
Same indication, different mechanism — what else might this patient receive?
Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.
What's emerging in CERETEC's indications
See all emerging drugs →Phase 3 candidates targeting molecules with no FDA-approved drug, in indications CERETEC treats. First-in-class if their pivotal trials read out positive.
Drugs Similar to CERETEC
3 of 20FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
CERETEC FDA Label Details
Indications & Usage
FDA Label (PDF)CERETEC is indicated for the treatment of Stroke; Intra-Abdominal Infection; Inflammatory Bowel Disease.
Track CERETEC with TheraRadar Pro
Watchlist alerts, full database access, CSV exports across 14,000+ drugs.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.